Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder

Special NoticeNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in Bethesda, MD
  • Industry: Testing Laboratories and Services

Contract Details

Notice ID
NOI-PCA-NIDA-09054
Opportunity Type
Special Notice
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH
Posted Date
Tuesday, September 8, 2026
Response Deadline
Tuesday, September 15, 2026
PSC Code
Q301
Set-Aside
No Set Aside
Place of Performance
Bethesda, MD, 20892
Status
Active

Description

Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work.

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for testing laboratories and services with a set-aside for No Set Aside businesses in Bethesda, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.